Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy

Nat Med. 2007 Nov;13(11):1382-7. doi: 10.1038/nm1650. Epub 2007 Oct 28.


Measurements of early tumor responses to therapy have been shown, in some cases, to predict treatment outcome. We show in lymphoma-bearing mice injected intravenously with hyperpolarized [1-(13)C]pyruvate that the lactate dehydrogenase-catalyzed flux of (13)C label between the carboxyl groups of pyruvate and lactate in the tumor can be measured using (13)C magnetic resonance spectroscopy and spectroscopic imaging, and that this flux is inhibited within 24 h of chemotherapy. The reduction in the measured flux after drug treatment and the induction of tumor cell death can be explained by loss of the coenzyme NAD(H) and decreases in concentrations of lactate and enzyme in the tumors. The technique could provide a new way to assess tumor responses to treatment in the clinic.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Carbon Isotopes / metabolism
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Etoposide / administration & dosage
  • Lactate Dehydrogenases / metabolism
  • Lactic Acid / administration & dosage
  • Lactic Acid / metabolism
  • Lymphoma / drug therapy*
  • Lymphoma / enzymology
  • Lymphoma / pathology*
  • Magnetic Resonance Imaging* / methods
  • Magnetic Resonance Spectroscopy* / methods
  • Mice
  • Neoplasm Transplantation
  • Pyruvic Acid / administration & dosage
  • Pyruvic Acid / metabolism


  • Antineoplastic Agents, Phytogenic
  • Carbon Isotopes
  • Lactic Acid
  • Etoposide
  • Pyruvic Acid
  • Lactate Dehydrogenases